Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Sub-dissociative Dose Ketamine Dosing Study: Complete Statistical AnalysisIndependent statistical analysis of Sub-dissociative Dose Ketamine Dosing Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03714620).
- Sub-dissociative Ketamine for the Management of Acute Pediatric Pain: Complete Statistical AnalysisIndependent statistical analysis of Sub-dissociative Ketamine for the Management of Acute Pediatric Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01951963).
- Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM: Complete Statistical AnalysisIndependent statistical analysis of Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM: primary endpoint results, effect estimate with confidence interval, sample-size…
- Subacromial Corticosteroid Injection for Hemiplegic Shoulder Pain: Complete Statistical AnalysisIndependent statistical analysis of Subacromial Corticosteroid Injection for Hemiplegic Shoulder Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00597766).
- Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement: Complete Statistical AnalysisIndependent statistical analysis of Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03913702).
- Subclinical Cardiovascular Disease in Psoriatic Disease: Complete Statistical AnalysisIndependent statistical analysis of Subclinical Cardiovascular Disease in Psoriatic Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03228017).
- Subconjunctival Versus Direct Mitomycin C in Trabeculectomy: Complete Statistical AnalysisIndependent statistical analysis of Subconjunctival Versus Direct Mitomycin C in Trabeculectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04352660).
- Subcutaneous (SC) Bortezomib-Regimens for Patients With RR MM Failing Prior IV Bortezomib-Containing Regimens: Complete Statistical AnalysisIndependent statistical analysis of Subcutaneous (SC) Bortezomib-Regimens for Patients With RR MM Failing Prior IV Bortezomib-Containing Regimens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Subcutaneous Fat Reduction in the Submental Area: Complete Statistical AnalysisIndependent statistical analysis of Subcutaneous Fat Reduction in the Submental Area: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02298322).
- Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT): Complete Statistical AnalysisIndependent statistical analysis of Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01489020).
- Subcutaneous Ketamine for Postoperative Pain Relief in Rwanda: Complete Statistical AnalysisIndependent statistical analysis of Subcutaneous Ketamine for Postoperative Pain Relief in Rwanda: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02514122).
- Subcutaneous Lidocaine For Cancer-Related Pain: Complete Statistical AnalysisIndependent statistical analysis of Subcutaneous Lidocaine For Cancer-Related Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01384877).
- Subcutaneous Pharmacokinetics of Belatacept: Complete Statistical AnalysisIndependent statistical analysis of Subcutaneous Pharmacokinetics of Belatacept: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00569803).
- Subcutaneous Progesterone Versus Vaginal Progesterone Tablets for Luteal Phase Support in In Vitro Fertilization (IVF): Complete Statistical AnalysisIndependent statistical analysis of Subcutaneous Progesterone Versus Vaginal Progesterone Tablets for Luteal Phase Support in In Vitro Fertilization (IVF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL): Complete Statistical AnalysisIndependent statistical analysis of Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL): primary endpoint results, effect estimate with confidence…
- Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism: Complete Statistical AnalysisIndependent statistical analysis of Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02504541).
- Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema: Complete Statistical AnalysisIndependent statistical analysis of Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00097695).
- Subcutaneous vs. Intramuscular Testosterone: Complete Statistical AnalysisIndependent statistical analysis of Subcutaneous vs. Intramuscular Testosterone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03091348).
- Subcuticular Absorbable Staples Versus Conventional Skin Closure in Women Undergoing Cesarean Delivery: Complete Statistical AnalysisIndependent statistical analysis of Subcuticular Absorbable Staples Versus Conventional Skin Closure in Women Undergoing Cesarean Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Subdissociative Dose Ketamine for Treatment of Acute Pain in Subjects With Chronic Pain: Complete Statistical AnalysisIndependent statistical analysis of Subdissociative Dose Ketamine for Treatment of Acute Pain in Subjects With Chronic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Subharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Subharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02115607).
- Subject Preference for Scalp Psoriasis Treatment: Complete Statistical AnalysisIndependent statistical analysis of Subject Preference for Scalp Psoriasis Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00438399).
- Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%: Complete Statistical AnalysisIndependent statistical analysis of Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%: primary endpoint results, effect estimate with confidence interval, sample-size…
- Subject´s Preference Regarding Hearing Performance and Functionality Using a New Sound Processor: Complete Statistical AnalysisIndependent statistical analysis of Subject´s Preference Regarding Hearing Performance and Functionality Using a New Sound Processor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Subjective Evaluation of a Commercially Marketed Contact Lens Amongst a Subset of the Contact Lens Wearing Population: Complete Statistical AnalysisIndependent statistical analysis of Subjective Evaluation of a Commercially Marketed Contact Lens Amongst a Subset of the Contact Lens Wearing Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Subjective Wearing Experience of the Total30 for Astigmatism Lens Among Satisfied Biofinity Toric Lens Wearers: Complete Statistical AnalysisIndependent statistical analysis of Subjective Wearing Experience of the Total30 for Astigmatism Lens Among Satisfied Biofinity Toric Lens Wearers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sublingual Sufentanil vs Intravenous Fentanyl for Acute Pain in the Ambulatory Surgery Center: Complete Statistical AnalysisIndependent statistical analysis of Sublingual Sufentanil vs Intravenous Fentanyl for Acute Pain in the Ambulatory Surgery Center: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Sublingual vs IV Atropine Bioavailability Study: Complete Statistical AnalysisIndependent statistical analysis of Sublingual vs IV Atropine Bioavailability Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04290039).
- SUBLOCADE Rapid Initiation Study: Complete Statistical AnalysisIndependent statistical analysis of SUBLOCADE Rapid Initiation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03993392).
- Suboptimal Responders to Adefovir Switching to Entecavir: Complete Statistical AnalysisIndependent statistical analysis of Suboptimal Responders to Adefovir Switching to Entecavir: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00718887).
- SUBQ-HFIndependent statistical analysis of Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03170219).
- SubQStim: A Post-market Study of Subcutaneous Nerve Stimulation in Failed Back Surgery Syndrome (FBSS) Patients: Complete Statistical AnalysisIndependent statistical analysis of SubQStim: A Post-market Study of Subcutaneous Nerve Stimulation in Failed Back Surgery Syndrome (FBSS) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Subsequent Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Subsequent Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder: Complete Statistical AnalysisIndependent statistical analysis of Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00383786).
- Substance P Challenge in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Substance P Challenge in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04676763).
- Substituting Sitting With Standing and Walking in Free-living Conditions Improves Daily Glucose Profile in South Asians: Complete Statistical AnalysisIndependent statistical analysis of Substituting Sitting With Standing and Walking in Free-living Conditions Improves Daily Glucose Profile in South Asians: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Substudy – Low Dose of Abatacept in Subjects With Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02): Complete Statistical AnalysisIndependent statistical analysis of Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02): primary endpoint results, effect estimate with…
- SUCCEEDIndependent statistical analysis of The SUCCEED Trial of Secondary Stroke Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01763203).
- Success of Pediatric Anesthesiologists in Learning to Use Videolaryngoscopes: Complete Statistical AnalysisIndependent statistical analysis of Success of Pediatric Anesthesiologists in Learning to Use Videolaryngoscopes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01215422).
- Success Rate of 4 Injection Protocols for Mandibular First Molars With Symptomatic Irreversible Pulpitis: Complete Statistical AnalysisIndependent statistical analysis of Success Rate of 4 Injection Protocols for Mandibular First Molars With Symptomatic Irreversible Pulpitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Succinylcholine Versus Rocuronium for Emergency Intubation in Intensive Care: Complete Statistical AnalysisIndependent statistical analysis of Succinylcholine Versus Rocuronium for Emergency Intubation in Intensive Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00355368).
- Suction Cervical Stabilizer Compared to Standard Tenaculum for Intrauterine Procedures: Complete Statistical AnalysisIndependent statistical analysis of Suction Cervical Stabilizer Compared to Standard Tenaculum for Intrauterine Procedures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06193590).
- Sufentanil Infusion vs Sufentanil Bolus: Complete Statistical AnalysisIndependent statistical analysis of Sufentanil Infusion vs Sufentanil Bolus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04226495).
- Sugammadex and Decreased Time to Extubation: Complete Statistical AnalysisIndependent statistical analysis of Sugammadex and Decreased Time to Extubation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03196167).
- Sugammadex and Quantitative Monitoring in “Fast-Track Anesthesia” During Liver Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Sugammadex and Quantitative Monitoring in "Fast-Track Anesthesia" During Liver Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05216991).
- Sugammadex Provide Better Surgical Condition Compared With Neostigmine in Laryngeal Microsurgery.: Complete Statistical AnalysisIndependent statistical analysis of Sugammadex Provide Better Surgical Condition Compared With Neostigmine in Laryngeal Microsurgery.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular: Complete Statistical AnalysisIndependent statistical analysis of Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03322657).
- SUHRIIndependent statistical analysis of The Substance Use and Health Risk Intervention (SUHRI) for Justice-involved Youth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Suicide Prevention for Criminal Legal Involved Managed Care Subscribers: Complete Statistical AnalysisIndependent statistical analysis of Suicide Prevention for Criminal Legal Involved Managed Care Subscribers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05579600).